Clover Health Investments, Corp. CLOV
3.73 USD -0.04 (-1.06%)
Regular-session close
3.75 +0.02 +0.57%
After hours · Nov 20, 7:55 PM ET
3.68 Day range 3.96
1.58 52-week range 5.59
- YTD
- +58.72%
- 1 year
- +72.69%
News
benzinga.com UnitedHealth Stock Slips: What's Going On? UnitedHealth Group shares are still falling Thursday, extending losses after CMS' proposed anti-fraud rule weighed on managed care stocks.
benzinga.com Medicare, Medicaid Overhaul Targets Fraudulent Billing and Unauthorized Marketplace Enrollments Federal regulators propose sweeping Medicare, Medicaid, and Marketplace anti-fraud reforms projected to save taxpayers nearly $90 billion.benzinga.com UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $5.5 UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and raises the price target from $5 to $5.5.
benzinga.com Clover Health Investments Raises FY2026 Sales Guidance from $2.920B-$3.000B to $2.970B-$3.000B vs $2.954B Est Clover Health Investments (NASDAQ:CLOV) raises FY2026 sales outlook from $2.920 billion-$3.000 billion to $2.970 billion-$3.000 billion vs $2.954 billion estimate.
benzinga.com Clover Health Investments Q3 EPS $0.01 Beats $(0.00) Estimate, Sales $759.304M Beat $738.423M Estimate Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.00) by Infinity percent. This is a 120 percent increase over…
benzinga.com This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday Analysts initiated coverage with Buy/Overweight ratings on KZIA ($27), PSQL ($12), NSRX ($7) and LGCY ($16).
benzinga.com This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
benzinga.com This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Analysts initiated coverage: Hold ALHC; Overweight/$6 SPRO; Buy/$3 LABT; Buy/$6 CLOV.benzinga.com Needham Initiates Coverage On Clover Health Investments with Buy Rating, Announces Price Target of $6 Needham analyst Matthew Shea initiates coverage on Clover Health Investments (NASDAQ:CLOV) with a Buy rating and announces Price Target of $6.
